Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-21
DOI
10.3389/fonc.2019.01491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ONECUT2 is a driver of neuroendocrine prostate cancer
- (2019) Haiyang Guo et al. Nature Communications
- HIF Inhibitors: Status of Current Clinical Development
- (2019) Jaleh Fallah et al. Current Oncology Reports
- Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis
- (2019) Xuejiao Sun et al. Molecular Medicine Reports
- Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer
- (2019) Kyung Chan Park et al. FREE RADICAL BIOLOGY AND MEDICINE
- EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers
- (2018) Rama Soundararajan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Molecular model for neuroendocrine prostate cancer progression
- (2018) Ruiqi Chen et al. BJU INTERNATIONAL
- Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis
- (2018) Tongyi Lu et al. CANCER SCIENCE
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
- (2018) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation
- (2018) Kenichiro Ishii et al. PROSTATE
- Molecular cross-talk of IL-6 in tumors and new progress in combined therapy
- (2018) Zuoqing Song et al. Thoracic Cancer
- Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
- (2018) Loredana Puca et al. Cold Spring Harbor Perspectives in Medicine
- Targeted Therapy and Immune Therapy for Small Cell Lung Cancer
- (2018) Shirish M. Gadgeel CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
- (2018) Yan Zhang et al. Nature Communications
- The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
- (2018) Ali Masjedi et al. BIOMEDICINE & PHARMACOTHERAPY
- ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
- (2018) Mirja Rotinen et al. NATURE MEDICINE
- EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis
- (2018) Jingnan An et al. ONCOGENE
- SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
- (2017) Yinan Li et al. EUROPEAN UROLOGY
- FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate
- (2017) Jung Wook Park et al. MODERN PATHOLOGY
- Biology and evolution of poorly differentiated neuroendocrine tumors
- (2017) David S Rickman et al. NATURE MEDICINE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation
- (2017) Jaspal Garg et al. Oncotarget
- Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis
- (2017) Kyunghee Noh et al. Cell Reports
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
- (2017) Ahmed M. Al-Abd et al. Journal of Advanced Research
- Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors
- (2016) MONICA CAPOZZI et al. ANTICANCER RESEARCH
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
- (2016) Etienne Dardenne et al. CANCER CELL
- Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment
- (2016) Ilaria Marech et al. CANCER LETTERS
- Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients
- (2016) Mimma Bianco et al. CANCER RESEARCH
- RETmutation and increased angiogenesis in medullary thyroid carcinomas
- (2016) Antonella Verrienti et al. ENDOCRINE-RELATED CANCER
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1
- (2016) M Hulsurkar et al. ONCOGENE
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells
- (2016) Meixiang Sang et al. Oncotarget
- The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells
- (2016) Mark P. Labrecque et al. Oncotarget
- Molecular landscape of prostate cancer: Implications for current clinical trials
- (2015) Galina Khemlina et al. CANCER TREATMENT REVIEWS
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- Regulation of tumor cell plasticity by the androgen receptor in prostate cancer
- (2015) J. L. Bishop et al. ENDOCRINE-RELATED CANCER
- Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway
- (2015) Sang Hoon Rhee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Polycomb-mediated silencing in neuroendocrine prostate cancer
- (2015) Pier-Luc Clermont et al. Clinical Epigenetics
- Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
- (2015) Panagiotis J. Vlachostergios et al. Frontiers in Oncology
- Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
- (2015) Chang-Deng Hu et al. Frontiers in Oncology
- Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
- (2015) Dong Lin et al. Oncotarget
- Chromogranin A: a paradoxical player in angiogenesis and vascular biology
- (2014) Karen B. Helle et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies
- (2014) Vincenza Conteduca et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Angiogenesis and vascular maturation in neuroendocrine tumors
- (2014) Samaneh Yazdani et al. HUMAN PATHOLOGY
- Meta-analysis of the effects of beta blocker on survival time in cancer patients
- (2014) Chel Hun Choi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- RET Mutations in Neuroendocrine Tumors: Including Small-Cell Lung Cancer
- (2014) Charles M. Rudin et al. Journal of Thoracic Oncology
- Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
- (2014) L Melchor et al. LEUKEMIA
- Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells
- (2014) Pei-Ching Chang et al. PLoS One
- GRK3 is essential for metastatic cells and promotes prostate tumor progression
- (2014) W. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
- (2014) Stéphane Terry et al. Frontiers in Oncology
- Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study
- (2013) Signy Holmes et al. Cancer Epidemiology
- p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway
- (2013) M Farhang Ghahremani et al. CELL DEATH AND DIFFERENTIATION
- Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
- (2013) H.-L. Tan et al. CLINICAL CANCER RESEARCH
- Thrombospondin-1 in Urological Cancer: Pathological Role, Clinical Significance, and Therapeutic Prospects
- (2013) Yasuyoshi Miyata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Behavioral stress accelerates prostate cancer development in mice
- (2013) Sazzad Hassan et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of NDRG1 in the pathology and potential treatment of human cancers
- (2013) Dong-Hun Bae et al. JOURNAL OF CLINICAL PATHOLOGY
- Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma
- (2013) Carmelle Romain et al. JOURNAL OF PEDIATRIC SURGERY
- ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation
- (2013) F Kosari et al. ONCOGENE
- Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer
- (2013) O B Goodman et al. PROSTATE CANCER AND PROSTATIC DISEASES
- EZH2, an epigenetic driver of prostate cancer
- (2013) Yeqing Angela Yang et al. Protein & Cell
- Thrombospondin-1 Mimetic Peptide ABT-898 Affects Neovascularization and Survival of Human Endometriotic Lesions in a Mouse Model
- (2012) Diane S. Nakamura et al. AMERICAN JOURNAL OF PATHOLOGY
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
- (2012) Shinichi Yachida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Angiogenesis in prostate cancer: onset, progression and imaging
- (2012) Giovanna Russo et al. BJU INTERNATIONAL
- A new chromogranin A-dependent angiogenic switch activated by thrombin
- (2012) L. Crippa et al. BLOOD
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- Angiopoietins in angiogenesis
- (2012) Ernesta Fagiani et al. CANCER LETTERS
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study of Thrombospondin-1 Mimetic Peptides, ABT-510 and ABT-898, in Dogs with Soft Tissue Sarcoma
- (2012) A.I. Sahora et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- p21-Activated kinase 4 promotes prostate cancer progression through CREB
- (2012) M-H Park et al. ONCOGENE
- PGE2 promotes angiogenesis through EP4 and PKA C pathway
- (2011) Y. Zhang et al. BLOOD
- Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.
- (2011) Steven W. Cole et al. CLINICAL CANCER RESEARCH
- ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer
- (2011) N. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- Using β-blockers to inhibit breast cancer progression
- (2011) Desmond G. Powe et al. Nature Reviews Clinical Oncology
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
- (2011) Michiel Smits et al. PLoS One
- Neuroendocrine tumor cells in prostate cancer: Evaluation of the neurosecretory products serotonin, bombesin, and gastrin - impact on angiogenesis and clinical follow-up
- (2011) Elmar Heinrich et al. PROSTATE
- Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes
- (2011) A. Aparicio et al. Cancer Discovery
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
- (2010) Louis B. Nabors et al. ARCHIVES OF NEUROLOGY
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors
- (2010) Jianfei Qi et al. CANCER CELL
- A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
- (2010) Michael R. Harrison et al. INVESTIGATIONAL NEW DRUGS
- VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway
- (2010) Karine Villaume et al. NEUROENDOCRINOLOGY
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
- (2009) Meng-Lei Zhu et al. FASEB JOURNAL
- Angiogenesis as a strategic target for prostate cancer therapy
- (2009) Yong Li et al. MEDICINAL RESEARCH REVIEWS
- A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer
- (2008) Michael S. Gordon et al. CANCER
- Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors
- (2008) A. B. Martinez-Cruz et al. CANCER RESEARCH
- A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
- (2008) E. I. Heath et al. CLINICAL CANCER RESEARCH
- Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma
- (2008) Laurence H. Baker et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started